Thursday, January 26 LIVE WEBINAR: Control-Alter-Delete: Epigenetic regulation by non-coding RNAs in neuronal systems
Presented by: Dr. Jeremy Day, Assistant Professor in the Department of Neurobiology at the University of Alabama
Abstract of Presentation: Emerging evidence suggests that non-coding RNAs can interact with epigenetic modifiers to both recruit and suppress epigenetic mechanisms, and that this functions can be regulated by activity states of neurons. Register today to join Dr Day as he highlights his recent work exploring how non-coding RNA species regulate DNA methylation in neuronal systems, including interactions between non-coding RNAs and DNA methyltransferases and genome-wide characterization of non-coding RNAs that arise from protein-coding genes , and reviews the functional modulation of non-coding RNAs in memory formation and behavior.
Wednesday, February 1 LIVE WEBINAR: Epithelial Mesenchymal Transition (EMT) in carcinoma
Presented by: Professor Jean Paul Thiery, Research Director Emeritus at the Institut Gustave Roussy, Comprehensive Cancer Center at Villejuif,and at the CNRS unit Matter and Complex Systems, Visiting Professor, School of Medicine of National University of Singapore (NUS), and at CCBIO University of Bergen
Abstract of Presentation: This webinar will review recent data on adhesive mechanisms involved in the maintenance of an epithelial state versus the transition to a mesenchymal-like phenotype, as well as discuss a number of studies in support of the concept that EMT contributes to tumor progression. Register today to join Professor Jean Paul Thiery, Research Director Emeritus at the Institut Gustave Roussy Comprehensive Cancer Center at Villejuif for this live webinar and Q&A session.
Thursday, February 2 LIVE WEBINAR: Targeting axonal transport in Alzheimer's disease
Presented by: Elizabeth Glennon, Ph.D, Alzheimer's Research UK fellow, Institute of Psychiatry, Psychology and Neuroscience at King's College London
Abstract of Presentation: Disruption of axonal transport is an early event in several neurodegenerative diseases. For this reason, it is a potential target for drug discovery. Register today to hear Dr Glennon discuss this exciting topic in Alzheimer's research including, how the disruption of axonal transport contributes to the development of Alzheimer's disease, and the mechanisms of axonal transport of the Alzheimer's amyloid precursor protein, and how these are altered in the disease.